OS Therapies
Rockville
About OS Therapies
OS Therapies operates as a clinical-stage therapeutic company focused on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors. It was launched to meet the significant unmet need for new treatments for cancers of the bone in kids and adults. The company has expanded the pipeline beyond Osteosarcoma with OST-HER2 into other solid tumors with the same recurrence mechanism of action, including breast, esophageal, and lung cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $37.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2026)
- Ticker: nyse:OSTX
- Website: ostherapies.com
Industries & Categories
Health Care, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/os-therapies-25955 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.